A case report highlights the use of immune modulatory therapy for treating severe dengue hemorrhagic fever in a patient with mitochondrial complex I deficiency. This study contributes to understanding potential therapeutic approaches for patients with rare mitochondrial disorders.
immune modulatory therapy for severe dengue hemorrhagic fever in a patient with mitochondrial complex i deficiency a case report
Original title: “Immune Modulatory Therapy for Severe Dengue Hemorrhagic Fever in a Patient With Mitochondrial Complex I Deficiency: A Case Report.”